These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 13737999)
1. Live virus immunizing agents. PRIER JE J Am Vet Med Assoc; 1960 Nov; 137():577-84. PubMed ID: 13737999 [No Abstract] [Full Text] [Related]
2. Viral vectors for use in the development of biodefense vaccines. Lee JS; Hadjipanayis AG; Parker MD Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875 [TBL] [Abstract][Full Text] [Related]
3. Live viral vaccines in patients with DiGeorge syndrome. Sullivan KE Clin Immunol; 2004 Oct; 113(1):3. PubMed ID: 15380522 [No Abstract] [Full Text] [Related]
4. [New virus vaccines]. WESSLEN T Nord Med; 1962 Apr; 67():501-7. PubMed ID: 14006280 [No Abstract] [Full Text] [Related]
5. [On the relations between the immunogenic activity of anti-virosis vaccines and their infectivity]. PORTOCALA R Stud Cercet Inframicrobiol; 1960; 11():365-73. PubMed ID: 13737335 [No Abstract] [Full Text] [Related]
6. A procedure for evaluating the antigenicity of killed virus vaccines for equine rhinopneumonitis. DOLL ER; BRYANS JT; McCOLLUM WH Cornell Vet; 1959 Apr; 49(2):212-20. PubMed ID: 13639583 [No Abstract] [Full Text] [Related]
7. A shot in the arm for immunotherapy. Griffiths PD Rev Med Virol; 2005; 15(4):215-7. PubMed ID: 15962359 [No Abstract] [Full Text] [Related]
8. Sheep pox and its control in Egypt using a desiccated live virus vaccine. SABBAN MS Am J Vet Res; 1955 Apr; 16(59):209-13. PubMed ID: 14361918 [No Abstract] [Full Text] [Related]
9. New Cells for New Vaccines II: Focus on Respiratory Virus Diseases. Egan W; Schild G Biologicals; 2008 Nov; 36(6):345. PubMed ID: 18757211 [No Abstract] [Full Text] [Related]
10. Specific immunoprophylaxis of some viral diseases in cattle. Rola J; Polak MP; Zmudziński JF Pol J Vet Sci; 2005; 8(4):315-21. PubMed ID: 16385857 [TBL] [Abstract][Full Text] [Related]
12. [Should we vaccinate patients with systemic lupus]. Wiesik-Szewczyk E; Lacki JK; Chwalińiska-Sadowska H Pol Merkur Lekarski; 2007 Nov; 23(137):395-8. PubMed ID: 18361328 [TBL] [Abstract][Full Text] [Related]
13. [Proposals for guidelines for vaccination of adults infected with HIV-1 in the Czech Republic]. Jilich D; Machala L; Rozsypal H; Aster V; Stanková M Klin Mikrobiol Infekc Lek; 2008 Apr; 14(2):60-6. PubMed ID: 18756438 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges. Abdelmagid OY; Larson L; Payne L; Tubbs A; Wasmoen T; Schultz R Vet Ther; 2004; 5(3):173-86. PubMed ID: 15578450 [TBL] [Abstract][Full Text] [Related]
15. DNA vaccines for biodefence. Garmory HS; Perkins SD; Phillpotts RJ; Titball RW Adv Drug Deliv Rev; 2005 Jun; 57(9):1343-61. PubMed ID: 15935877 [TBL] [Abstract][Full Text] [Related]
16. Current developments in viral DNA vaccines: shall they solve the unsolved? Rajcáni J; Mosko T; Rezuchová I Rev Med Virol; 2005; 15(5):303-25. PubMed ID: 15906276 [TBL] [Abstract][Full Text] [Related]
17. Bibliography. Current world literature. Pathogenesis and immune response. Curr Opin Infect Dis; 2007 Jun; 20(3):329-44. PubMed ID: 17563953 [No Abstract] [Full Text] [Related]